Skip to main navigation Skip to search Skip to main content

Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex

  • Wei Si
  • , Leah Aluisio
  • , Naoe Okamura
  • , Stewart D. Clark
  • , Ian Fraser
  • , Steven W. Sutton
  • , Pascal Bonaventure
  • , Rainer K. Reinscheid
  • University of California at Irvine
  • Johnson & Johnson
  • Chiba University

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Abstract

Neuropeptide S (NPS) is known to produce anxiolytic-like effects and facilitate extinction of conditioned fear. Catecholaminergic neurotransmission in the medial prefrontal cortex (mPFC) has been suggested to be crucially involved in these brain functions. In the current study, we investigated the effect of NPS on the release of dopamine and serotonin in the mPFC by in vivo microdialysis in rats. Central administration of NPS dose-dependently enhanced extracellular levels of dopamine and its major metabolite 3,4- dihydroxyphenylacetic acid, with maximal effects lasting up to 120 min. In contrast, no effect on serotonergic neurotransmission was detected. Dopamine release in the mPFC has been previously linked to modulation of anxiety states and fear extinction. The present results may thus provide a physiological and anatomical basis for the reported effects of NPS on these behaviors.

Original languageEnglish
Pages (from-to)475-482
Number of pages8
JournalJournal of Neurochemistry
Volume115
Issue number2
DOIs
StatePublished - Oct 2010

Keywords

  • Cortex
  • Dopamine
  • Microdialysis
  • Neuropeptide
  • Rat
  • Serotonin

Fingerprint

Dive into the research topics of 'Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex'. Together they form a unique fingerprint.

Cite this